Sector Chart Carmell Corporation

Equities

CTCX

US1429221039

Delayed Nasdaq 16:20:19 26/06/2024 BST 5-day change 1st Jan Change
1.23 USD -1.60% Intraday chart for Carmell Corporation -19.08% -67.72%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
25.71M - - - - -
122B
116B
27.03B -
20.36B -
16.43B